Neurocrine Biosciences reported $6.6M in Interest Expense on Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Adamas Pharmaceuticals ADMS:US 3.5M 28K
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
ALKERMES ALKS:US 2.44M 30K
Alnylam Pharmaceuticals ALNY:US $ 40.27M 6.86M
Amgen AMGN:US $ 296M 15M
Biogen BIIB:US $ 66.3M 9.9M
Biomarin Pharmaceutical BMRN:US $ 3.87M 0.05M
Cytokinetics CYTK:US $ 4.16M 0.09M
Gilead Sciences GILD:US $ 250M 6M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Halozyme Therapeutics HALO:US $ 1.75M 0M
Intercept Pharmaceuticals ICPT:US $ 14.1M 1.51M
IONIS PHARMACEUT IONS:US $ 2.34M 0.02M
Nektar Therapeutics NKTR:US $ 12.8M 0.29M
Neurocrine Biosciences NBIX:US $ 6.6M 0.4M
Pfizer PFE:US $ 325M 9M
Regeneron Pharmaceuticals REGN:US $ 14.2M 0.2M
Repligen RGEN:US $ 3.22M 0.08M
Rigel Pharmaceuticals RIGL:US $ 1.32M 0.44M
Sarepta Therapeutics SRPT:US $ 16M 0.16M
Teva Pharmaceutical TEVA:IT 232M 8M
Vertex Pharmaceuticals VRTX:US $ 15.26M 0.22M
Xoma XOMA:US $ 0 172K
YTE INCY:US $ 0.44M 0.08M
Zogenix ZGNX:US $ 3.85M 0.06M